Clinical Follow-up of Isolated Myocardial Bridge
(PCI) or coronary artery bypass graft surgery (CABG)]. In addition, we excluded patients with any other risk factor causing chest pain (ie, valvular heart disease, cardiomyopathy, congenital heart disease, myocarditis, significant arrhythmia, pulmonary disease, gastrointestinal disease). The patients were divided into 2 groups according to the presence of a MB.
Cardiac catheterization was performed and quantitative diameter measurements of the coronary arteries and MB were obtained by a 2-board certified invasive cardiologist using a workstation with dedicated software (Phillips H5000 or Allura DCI program). Cases of MB were identified angiographically as an intramyocardial systolic compression or milking of a segment of an epicardial coronary artery. Intracoronary nitroglycerin was administered once MB was suspected during CAG, for the purpose of defining the extent of impingement of the MB. A long MB was defined as >20 mm and severe systolic compression was defined as >70% systolic lumen diameter reduction. 8, 13 Demographic and clinical characteristics, including age, sex, cardiovascular risk factors (hypertension, diabetes mellitus, hyperlipidemia, smoking status, familial history of coronary heart disease), and comorbidities were identified. A 12-lead ECG was recorded and analyzed for all patients by the attending physicians and/or cardiologist. Treadmill exercise test, myocardial scintigraphy was performed for patients with stable AP and low risk of unstable AP. Left ventricular ejection fraction was determined on 2D echocardiography performed during the index hospitalization. Blood sampling for baseline laboratory tests, except lipid measurement, were collected at admission or before CAG. Overnight fasting blood was also sampled for lipid levels.
Follow-up data were obtained from direct telephone contact and hospital and computer records. Review of all available medical records was performed for in-hospital and late outcomes. The primary endpoint was readmission during the follow-up period. Readmission comprised: recurrent chest pain refractory to medical therapy, death, non-fatal MI, or Abbreviations see in Table 1 . Clinical Follow-up of Isolated Myocardial Bridge <5) was used to determine the significance of differences in categorical variables. The incidence of readmission was compared using Cox proportional hazards model. All statistical tests were 2-tailed, and P<0.05 was considered statistically significant. The study was approved by the institutional review board. Patients were excluded if no prior authorization for medical records research was given.
Results
The total number of the patients with CAG analysis was 7,869 and the total number of cases of <50% stenosis was 684 (8.6%) and of isolated MB with <50% stenosis was 308 (3.9%).
Baseline Characteristics and Presentation
Mean age was 60.59±11.02 years and 50.1% were men. Table 1 shows the demographics and baseline characteristics of the 2 groups based on the presence of MB. There were no significant differences in sex or cardiovascular risk factors. However, young age, symptoms of unstable AP or elevated cardiac enzymes commonly accompanied a MB.
Clinical Follow-up
After a mean follow-up of 37.2±14.9 months, 91 (13.3%) patients were readmitted: 79 (11.5%) cases of recurrent chest pain refractory to medication, 8 (1.2%) non-fatal MIs, 1 (0.3%) life-threatening arrhythmia and 4 (0.6%) non-cardiovascular deaths. Two patients died of sepsis, 1 patient died of pneumonia and 1 patient died of cancer progression. Figure) . Table 4 shows the CAG features in the MB group. MB can affect any of the major epicardial coronary arteries, but involvement of the left anterior descending (LAD) was most common and the most commonly reported location of the MB was in the mid-LAD. Spontaneous vasospasm frequently accompanied the MB. There was no significant difference in atherosclerosis in the bridging and non-bridging coronary arteries on CAG.
CAG Analysis of MB Group

Discharge Medication in the MB Group
Medications at the time of discharge in the MB group are listed in Table 5 . All MB patients were prescribed a BB or CCB as recommended in the current therapeutic guideline. CCB tended to be prescribed to patients with coronary vasospasm on CAG.
Risk Factors of Readmission in the MB Group
Multivariable analysis showed that MB >20 mm (HR 2.780, 95%CI 1.070-7.218, P=0.036) and spontaneous vasospasm on CAG (HR 2.335, 95%CI 1.055-5.171, P<0.037) were independent predictors of readmission after adjustment for clinical, angiographic and procedural data ( Table 6 ). Additional use of aspirin or statin decreased the readmission rate (HR 0.247, 95%CI 0.109-0.560, P<0.001 and HR=0.455, 0.218-0.950, P=0.036, respectively).
Discussion
The main findings of this study are: (1) a prevalence of MB of 3.9% and most commonly seen in the mid segment of the LAD on angiography, (2) MB with non-occlusive CAG is signaled by the complaint of chest pain in younger aged patients, regardless of sex, (3) unstable AP and MI are common presentations in patients with MB, (4) spontaneous Table 1 .
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vasospasm is a common angiographic finding in MB, and (5) MB is not a harmless condition and recurrent hospitalization is common. During the follow-up, approximately 20% of the patients had to be readmitted because of presumed or proven cardiac events. Readmission for recurrent chest pain refractory to medical therapy and non-fatal MI were common in patients with MB. MB can cause ischemia even in the absence of coronary narrowing on CAG. On admission to hospital, elevated cardiac enzymes in 26 (8.5%) patients and ECG changes (ST change, pathologic Q wave, transient T wave inversion) in 22 (7.1%) patients suggested myocardial ischemia. In the clinical follow-up period, 7 (2.3%) patients were readmitted because of MI.
There are several hypotheses of how MB causes ischemia. Symptomatic MB itself is 1 cause. Long MB was a major risk factor of readmission in this study. The length of coronary arterial narrowing influences coronary hemodynamics and a delayed diastolic phase in cases of longer MB may contribute to myocardial ischemia, 14-16 which may explain why relatively long MB are observed in symptomatic patients. Also, a relative long MB may cause myocardial squeezing of the septal branch and the prognosis of patients with myocardial squeezing may be worsened. However, in this study, squeezing of a major side branch was not found on CAG. Comparatively, the site of the MB (m-LAD) and severe systolic compression of the MB did not significantly affect readmission.
Coronary vasospasm, as an alternative mechanism, may be associated with MB. 17 The systolic milking of the vessel may produce endothelial damage, which may stimulate platelet aggregation and coronary vasospasm. 12 This would explain why spontaneous vasospasm was relatively common in the MB group and was a major predictor of readmission during clinical follow-up.
Management of symptomatic patients with MB is still controversial. The current guideline suggests medical therapy with a BB or CCB as first-line treatment. 18 CCBs are recommended for vascular endothelial function in patients with coronary spastic angina. 19 However, conventional therapy was insufficient to treat recurrent chest pain in the MB patients. We did not find any correlation between medical therapy and modification of the outcome of MB, but additional use of aspirin or statin was useful for MB and lowered the readmission rate in those refractory to conventional medical therapy (CCB, BB). It is known that enhanced platelet aggregation is a physiological factor influencing the occurrence of myocardial ischemia with symptomatic MB 12 and aspirin is known to prevent platelet aggregation and decrease the risk of cardiovascular disease. Also, statins affect atherosclerosis, stabilize microemboli and improve endothelial dysfunction. 20-22 Therefore, it is reasonable to administer aspirin or statin to MB patients with recurrent chest pain.
Study Limitations
This present study was limited because of its retrospective nature in a single center. However, this uncommon condition does not lend itself to randomization and so we reviewed charts and angiograms. The vasospasm provocation test was not performed in all patients because of empirical treatment with intracoronary nitroglycerin. We were not able to solve this because of the retrospective nature of the study. Also, there might be bias because we excluded MB with >50% stenosis in the coronary arteries and other risk factors causing chest pain (ie, valvular heart disease, cardiomyopathy, congenital heart disease, myocarditis, significant arrhythmia, pulmonary disease, gastrointestinal disease). Results of the present study cannot necessarily be generalized to the treatment of patients with MB in general practice. Future large, prospective studies are warranted. 
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Conclusions
The present study results suggest that MB with non-occlusive CAG is not benign and may cause recurrent chest pain, MI, and life-threatening arrhythmia. In particular, patients with a long MB and spontaneous vasospasm on CAG need intensive medical therapy, including antiplatelet treatment.
